(JIGB) JPMorgan Corporate Bond - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46641Q4495
JIGB: Corporate, Bonds, Investment-Grade, U.S., ETF
JPMorgan Corporate Bond Research Enhanced (JIGB) is an ETF that tracks a market-capitalization-weighted index of U.S. dollar-denominated investment-grade corporate debt issued in the U.S. domestic market. This index is a subset of the broader Bloomberg US Credit and Bloomberg US Aggregate indices, providing a focused exposure to the U.S. corporate bond market.
The funds investment strategy involves allocating at least 80% of its assets to securities included in the underlying index, ensuring a high degree of correlation with the overall performance of the tracked market segment. By doing so, JIGB offers investors a diversified portfolio of high-quality corporate bonds with a relatively low risk profile.
Analyzing the ETFs recent price action, we observe a stable trend with minimal volatility, as indicated by the narrow range between the 52-week high and low (45.79 and 42.37, respectively). The current price of 44.79 is near the SMA20, SMA50, and SMA200 levels (44.73, 44.82, and 44.77, respectively), suggesting a lack of strong directional momentum. The ATR of 0.30 (0.67%) further reinforces this observation, indicating relatively low price fluctuations.
Considering the funds AUM of $37.92M, we can infer that JIGB has a relatively modest asset base. While this may impact liquidity, it is not uncommon for niche or specialized ETFs. Given the current market conditions and the funds characteristics, we can forecast that JIGB will likely continue to track the underlying index closely, with potential for slight deviations due to tracking errors or changes in market sentiment.
Based on the technical and fundamental data, our forecast suggests that JIGB will experience a gradual price appreciation in the near term, driven by the overall stability of the U.S. corporate bond market and the funds low volatility profile. We anticipate the price to move towards the 52-week high of 45.79, potentially reaching 45.50 within the next few weeks, assuming no significant market disruptions or changes in investor sentiment.
Additional Sources for JIGB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
JIGB ETF Overview
Market Cap in USD | 39m |
Category | Corporate Bond |
TER | 0.09% |
IPO / Inception | 2018-12-12 |
JIGB ETF Ratings
Growth Rating | -8.31 |
Fundamental | - |
Dividend Rating | 53.1 |
Rel. Strength | 6.07 |
Analysts | - |
Fair Price Momentum | 44.00 USD |
Fair Price DCF | - |
JIGB Dividends
Dividend Yield 12m | 4.28% |
Yield on Cost 5y | 4.15% |
Annual Growth 5y | -0.43% |
Payout Consistency | 81.9% |
Payout Ratio | % |
JIGB Growth Ratios
Growth Correlation 3m | 54.9% |
Growth Correlation 12m | 35.7% |
Growth Correlation 5y | -44.5% |
CAGR 5y | -0.42% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | 0.69 |
Alpha | 1.37 |
Beta | 0.033 |
Volatility | 6.81% |
Current Volume | 1.2k |
Average Volume 20d | 1.7k |
As of July 01, 2025, the stock is trading at USD 45.44 with a total of 1,196 shares traded.
Over the past week, the price has changed by +0.45%, over one month by +1.64%, over three months by +1.36% and over the past year by +7.11%.
Neither. Based on ValueRay´s Analyses, JPMorgan Corporate Bond is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -8.31 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JIGB is around 44.00 USD . This means that JIGB is currently overvalued and has a potential downside of -3.17%.
JPMorgan Corporate Bond has no consensus analysts rating.
According to our own proprietary Forecast Model, JIGB JPMorgan Corporate Bond will be worth about 47.5 in July 2026. The stock is currently trading at 45.44. This means that the stock has a potential upside of +4.58%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 47.5 | 4.6% |